http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. (HealthDay)—Injections of a sugar solution appear to help relieve knee pain and stiffness related to osteoarthritis, a new study suggests. http://medicalxpress.com/news/2013-05-sugar-knee-arthritis-ease-pain.html Arthritis & Rheumatism Tue, 21 May 2013 07:30:01 EST news288336772 EPFL researchers develop a tool for oncologists using the electrical signature of cancer cells to get just the right treatment dosage for each patient. http://medicalxpress.com/news/2013-03-dose-oncology.html Cancer Mon, 04 Mar 2013 17:00:01 EST news281616375 In a new phase III trial mirabegron, a β3-adrenoceptor agonist, given once daily for 12 weeks, reduced the frequency of incontinence episodes and number of daily urinations, and improved urgency and nocturia in adults with overactive bladder (OAB) compared to those in a placebo group. The incidence of common adverse events (hypertension, urinary tract infection, headache, nasopharyngitis) was similar in the mirabegron and placebo groups in this study. Rates of dry mouth and constipation were similar in the drug and placebo groups. The study is published in the Journal of Urology. http://medicalxpress.com/news/2013-03-mirabegron-effective-tolerated-overactive-bladder.html Diseases, Conditions, Syndromes Mon, 04 Mar 2013 16:37:19 EST news281637433 (Medical Xpress)—Mistletoe has become an important symbol of Christmas but it also has the potential to play a vital role as an alternative therapy for Australian sufferers of colon cancer. http://medicalxpress.com/news/2012-11-mistletoe-treatment-colon-cancer.html Cancer Fri, 30 Nov 2012 08:38:32 EST news273487101 (Medical Xpress) -- Scientists have found that a protein expressed by some cancers is a good predictor of how the cancer will respond to standard chemotherapy for osteosarcoma, the most common bone cancer in children. Knowing whether a patient's tumor has this protein biomarker could help doctors determine if a patient should undergo standard treatment or if a more aggressive or alternative therapy may be more effective. The study findings were published in Human Pathology. http://medicalxpress.com/news/2012-07-biomarker-chemo-response-osteosarcoma.html Cancer Tue, 03 Jul 2012 13:44:58 EST news260541878 In the largest study of its kind, researchers have profiled genetic changes in cancer with drug sensitivity in order to develop a personalised approach to cancer treatments. The study is published in Nature on Thursday 29 March 2012. http://medicalxpress.com/news/2012-03-path-personalized-cancer-treatment.html Cancer Wed, 28 Mar 2012 13:00:03 EST news252151008 Stockholm, Sweden: Many prostate cancer patients develop bone metastases, and controlling the pain these cause can be difficult. Now the first large randomised Phase III trial of a bisphosphonate drug in these patients has shown that a single dose of the drug is as good for pain relief as single dose radiotherapy, the standard treatment for bone metastases. Results of the trial were presented today at the 2011 European Multidisciplinary Cancer Congress. http://medicalxpress.com/news/2011-09-bone-strengthening-drug-pain-relief-prostate.html Cancer Sun, 25 Sep 2011 13:28:41 EST news236176106 Researchers at The University of Nottingham are to investigate whether the therapeutic effects of clay modelling could help disturbed teenagers deal with their feelings of anger, anxiety and depression. http://medicalxpress.com/news/2011-08-emotions-potential-therapy-disturbed-teenagers.html Psychology & Psychiatry Tue, 23 Aug 2011 12:10:18 EST news233320191 Patients with HER2-positive breast cancer may soon have an alternative therapy when they develop resistance to trastuzumab, also known as Herceptin, according to a laboratory finding published in Clinical Cancer Research. http://medicalxpress.com/news/2011-07-therapy-her2-positive-breast-cancer.html Cancer Tue, 26 Jul 2011 13:00:06 EST news230885661